Novo Nordisk (NVO.N) fell more than 6% in U.S. premarket trading after unveiling its 2030 strategic targets.

2026-09-21

Novo Nordisk (NVO.N) fell more than 6% in U.S. premarket trading after unveiling its 2030 strategic targets.